"RNA, Messenger" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
Descriptor ID |
D012333
|
MeSH Number(s) |
D13.444.735.544
|
Concept/Terms |
mRNA, Polyadenylated- mRNA, Polyadenylated
- RNA, Messenger, Polyadenylated
- Messenger RNA, Polyadenylated
- Polyadenylated Messenger RNA
- RNA, Polyadenylated Messenger
- Polyadenylated mRNA
- Poly(A)+ mRNA
|
Below are MeSH descriptors whose meaning is more general than "RNA, Messenger".
Below are MeSH descriptors whose meaning is more specific than "RNA, Messenger".
This graph shows the total number of publications written about "RNA, Messenger" by people in this website by year, and whether "RNA, Messenger" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 10 | 37 | 47 |
1994 | 12 | 36 | 48 |
1995 | 3 | 47 | 50 |
1996 | 11 | 36 | 47 |
1997 | 9 | 52 | 61 |
1998 | 4 | 29 | 33 |
1999 | 3 | 36 | 39 |
2000 | 7 | 41 | 48 |
2001 | 5 | 57 | 62 |
2002 | 4 | 58 | 62 |
2003 | 5 | 64 | 69 |
2004 | 5 | 74 | 79 |
2005 | 5 | 43 | 48 |
2006 | 2 | 45 | 47 |
2007 | 8 | 47 | 55 |
2008 | 9 | 60 | 69 |
2009 | 4 | 40 | 44 |
2010 | 7 | 49 | 56 |
2011 | 3 | 42 | 45 |
2012 | 9 | 38 | 47 |
2013 | 11 | 32 | 43 |
2014 | 10 | 33 | 43 |
2015 | 16 | 37 | 53 |
2016 | 11 | 19 | 30 |
2017 | 9 | 22 | 31 |
2018 | 8 | 17 | 25 |
2019 | 15 | 13 | 28 |
2020 | 3 | 14 | 17 |
2021 | 5 | 15 | 20 |
2022 | 4 | 18 | 22 |
2023 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "RNA, Messenger" by people in Profiles.
-
DDX41-associated susceptibility to myeloid neoplasms. Blood. 2023 03 30; 141(13):1544-1552.
-
Analysis of genetically determined gene expression suggests role of inflammatory processes in exfoliation syndrome. BMC Genomics. 2023 Feb 16; 24(1):75.
-
Exon architecture controls mRNA m6A suppression and gene expression. Science. 2023 02 17; 379(6633):677-682.
-
BID-seq: The Quantitative and Base-Resolution Sequencing Method for RNA Pseudouridine. ACS Chem Biol. 2023 01 20; 18(1):4-6.
-
Quantification of extracellular proteins, protein complexes and mRNAs in single cells by proximity sequencing. Nat Methods. 2022 Dec; 19(12):1578-1589.
-
Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution. Nat Biotechnol. 2023 03; 41(3):344-354.
-
Odds of Hospitalization for COVID-19 After 3 vs 2 Doses of mRNA COVID-19 Vaccine by Time Since Booster Dose. JAMA. 2022 10 18; 328(15):1559-1561.
-
Long noncoding RNA uc.230/CUG-binding protein 1 axis sustains intestinal epithelial homeostasis and response to tissue injury. JCI Insight. 2022 10 10; 7(19).
-
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers. Commun Biol. 2022 10 06; 5(1):1061.
-
Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland. Nat Commun. 2022 09 28; 13(1):5701.